These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35321833)

  • 1. Establishing a Prognostic Model Based on Three Genomic Instability-related LncRNAs for Clear Cell Renal Cell Cancer.
    Lulu S; Hualing H; Shan Z; Dianxi C; Yiqing L; Qin L
    Clin Genitourin Cancer; 2022 Aug; 20(4):e317-e329. PubMed ID: 35321833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
    Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
    J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computational prognostic model of lncRNA signature for clear cell renal cell carcinoma with genome instability.
    Cui T; Guo J; Sun Z
    Expert Rev Mol Diagn; 2022 Feb; 22(2):213-222. PubMed ID: 34871123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma.
    Ma W; Zhong M; Liu X
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34402862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma.
    Zhang C; Huang D; Liu A; Xu Y; Na R; Xu D
    J Cell Biochem; 2020 Mar; 121(3):2559-2570. PubMed ID: 31646670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Somatic Mutation-Derived Long Non-Coding RNA Signatures of Genomic Instability in Renal Cell Carcinoma.
    Fang X; Liu X; Lu L; Liu G
    Front Oncol; 2021; 11():728181. PubMed ID: 34676164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer.
    Jiao Y; Li S; Wang X; Yi M; Wei H; Rong S; Zheng K; Zhang L
    Front Immunol; 2022; 13():929846. PubMed ID: 35990656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of genomic instability-associated long non-coding RNA signature: A prognostic risk model of clear cell renal cell carcinoma.
    Jiang D; Wu T; Shi N; Shan Y; Wang J; Jiang H; Wu Y; Wang M; Li J; Liu H; Chen M
    Front Oncol; 2022; 12():1019011. PubMed ID: 36387102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome instability-related long non-coding RNA in clear renal cell carcinoma determined using computational biology.
    Wang Y; Yan K; Wang L; Bi J
    BMC Cancer; 2021 Jun; 21(1):727. PubMed ID: 34167490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature.
    Wu H; Zhang ZY; Zhang Z; Xiao XY; Gao SL; Lu C; Zuo L; Zhang LF
    Bioengineered; 2021 Dec; 12(1):1725-1738. PubMed ID: 33955803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma.
    Jin C; Zhao JS; Huang XQ; Yang XZ; Niu FY; Lin JR; Ma L; Shi YX; Li XS; Jiang P; Gao S; Li F; Song Y
    Hepatol Int; 2022 Oct; 16(5):1220-1233. PubMed ID: 35947245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma.
    Zhang Z; Tang Y; Liu Y; Zhuang H; Lin E; Xie L; Feng X; Tian K; Zeng J; Liu J; Yu Y
    J Immunol Res; 2021; 2021():9921466. PubMed ID: 34368371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
    Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY
    Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Novel Genome Instability-associated lncRNAs and their Potential Function in Pan-Renal Cell Carcinoma.
    Zhu HX; Zheng WC; Chen H; Chen JY; Lin F; Chen SH; Xue XY; Zheng QS; Liang M; Xu N; Chen DN; Sun XL
    Comb Chem High Throughput Screen; 2024; 27(12):1788-1807. PubMed ID: 37957851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma.
    Su H; Wang H; Shi G; Zhang H; Sun F; Ye D
    Eur J Surg Oncol; 2018 Jun; 44(6):840-846. PubMed ID: 29433989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Interpretation of a Genomic Instability Derived lncRNAs Based Risk Signature as a Predictor of Prognosis for Clear Cell Renal Cell Carcinoma Patients.
    Yang H; Xiong X; Li H
    Front Oncol; 2021; 11():678253. PubMed ID: 34094983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Genomic Instability-Related Long Noncoding RNA Prognostic Model in Colorectal Cancer Based on Bioinformatic Analysis.
    Liang Y; Sun HX; Ma B; Meng QK
    Dis Markers; 2022; 2022():4556585. PubMed ID: 35711569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.